Diligence memo · auto-generated · as of July 3, 2026
Fulcrum Implant Systems, Inc.
Fulcrum Implant Systems, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Fulcrum Implant Systems, Inc. operates in Medical Devices, based in LAS VEGAS.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Fulcrum Implant Systems, Inc. has raised $11M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $11M on 2017-07-01.
Most recent recorded round closed around 2017-07-01.
Valuation (modeled)modeled
Provath models Fulcrum Implant Systems, Inc. at approximately $253M (range $13M–$1.4B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.05× the median modeled value of Series A Medical Devices companies in 2016–2018 (5 peers) — value vs value, same stage and era. Issuer reports no revenue, yet is modeled well above niche peers.
Financing rhythm & timingmixed
Last raise 9.0 yr ago; this sector typically re-raises about every 16 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 78% of Medical Devices peers (233 compared).
Modeled value ranks above 94% of those peers.
Closest niche peers: SafeOp Surgical, Inc., Acera Surgical, Inc., Reliant Immune Diagnostics, LLC, Medite Cancer Diagnostics, Inc..
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.